Biomedicine & Pharmacotherapy · 2024 · 12 citations · 115 references
Life SciencesImmunologyPathologyCellular ImmunologyImmunopathologyImmunoregulationCell-mediated ImmunityChronic Liver DiseaseCirrhosisLiver DiseaseT Cell ActivationT Cell BiologyHepatic Immune DysregulationHepatocellular Carcinoma PathogenesisImmune-mediated Hepatic InjuryImmune-mediated Liver InjuryImmunologic DysregulationLiver ImmunologyT Cell-mediated Immune ResponseT-cell Mediated Immune Response
Metabolic dysfunction-associated steatotic liver disease(MASLD), formerly known as non-alcoholic fatty liver disease(NAFLD), has become a major cause of chronic liver disease and a significant risk factor for hepatocellular carcinoma, which poses a huge burden on global public health and economy. MASLD includes steatotic liver disease, steatohepatitis, and cirrhosis, and the latter two cause great harm to human health and life, even complicated with liver cancer. Immunologic mechanism plays a major role in promoting its development into hepatitis and cirrhosis. Now more and more evidences show that T cells play an important role in the progression of MASLD. In this review, we discuss the double roles of T cells in MASLD from the perspective of T cell response pathways, as well as new evidences regarding the possible application of immunomodulatory therapy in MASH.
115
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu et al. · Hepatology · 2023 · 2.9K citations · Full text
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Henao‐Mejia, Eran Elinav, Chengcheng Jin et al. · Nature · 2012 · 2.4K citations
Life Sciences, Immunology, Pathology +12